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Abstract
Background: We have developed a 12-parameter/10-color flow cytometric staining method for the simultaneous
detection and characterization of 21 mouse thymocyte subpopulations that represent discreet stages of T cell
development. To demonstrate the utility of this method, we assessed cytokine receptor expression on mouse
thymocyte subsets. These experiments revealed distinct patterns of surface expression of receptors for the
cytokines IL-4 and IL-6.
Results: The IL-4 receptor a chain (CD124) was highly expressed on the earliest thymocyte subsets, then
downregulated prior to T cell receptor b-selection and finally upregulated in the CD4/CD8 double positive cells
prior to positive selection. The IL-6 receptor a chain (CD126) showed a different pattern of expression. It was
expressed on the most mature subsets within the CD4 and CD8 single positive (SP) compartments and was absent
on all other thymocytes with the exception of a very small cKit
-CD4
-CD8
- population. Intracellular staining of SP
thymocytes for phosphorylated STAT-1 demonstrated that IL-6 signaling was confined to the most mature SP
subsets.
Conclusions: This 12-parameter staining methodology uses only commercially available fluorochrome-coupled
monoclonal antibodies and therefore could be employed by any investigator with access to a 4-laser flow
cytometer. This novel staining scheme allowed us to easily phenotype thymocyte subpopulations that span across
development, from the early thymic progenitors (ETPs) to the most mature subsets of the CD4 and CD8 single
positive populations.
Background
Recent studies, including fate mapping using OP9-DL1
stromal cells (reviewed in [1]), have allowed for finer
discrimination and sequential ordering of a number of
discreet thymocyte subpopulations. Due to the large
number of different surface antigens used as markers for
identification of each subset (Figure 1), it has become
increasingly difficult to perform comprehensive pheno-
typing of mouse thymopoiesis by flow cytometry. Many
investigators have been forced to rely on cell sorting
prior to phenotype staining or to focus on either early
or late development in order to assess subsets with finer
resolution. We have focused on the development of phe-
notyping stains that target thymocytes across all of the
major stages of maturation without the need for pre-
sorting. As described below, these stages of maturation
can be finely assessed using flow cytometric analysis of
a number of surface antigens that are unique to each
stage.
Traditionally, the major murine thymocyte compart-
ments are defined by expression of the CD4 and CD8
antigens [2]. The most immature cells are negative for
both antigens (DN), whereas cells of intermediate
maturity are double positive (DP) for CD4 and CD8.
The DP cells give rise to the most mature cells which
a r es i n g l ep o s i t i v ef o re i t h e rC D 8( S P 8 )o rC D 4( S P 4 )
[3,4]. These four major compartments have been further
divided into at least 18 discreet subpopulations as
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which are depicted in Figure 1. Important checkpoints
that determine whether thymocytes live or die are noted
in this figure as well. The first major checkpoint occurs
in the DN3 compartment where only cells that success-
f u l l ye x p r e s saT C R b chain are selected to continue
maturation [11]. Cells in the DN3 compartment that are
pre-or post-b-selection can be discriminated into DN3a
and DN3b subsets, respectively, based on CD28 [10] or
CD27 expression [12]. As depicted in Figure 1 and
recently described by us using OP9-DL1 fate mapping
assays [13], DN cells that are pre and post b-selection
and those between b-selection and the DP stage can be
finely resolved using CD25 and CD28 staining. It is in
the DP compartment that positive selection occurs
(reviewed in [14]) and this compartment can be divided
into those cells that are negative/low for TCR expres-
sion, those that have intermediate TCR expression and
those cells that are TCR high/CD69 high which are the
cells that have just undergone positive selection. Finally,
the small percentage of cells that mature into the SP4
and SP8 populations progressively lose expression of
CD24 (heat stable antigen) until ready for entry into the
periphery [15] and thus can be divided into semi-mature
SP and mature SP subsets based on level of this antigen.
It is during the SP stages that negative selection occurs
(reviewed in [6]).
Throughout thymocyte development, the regulation of
access and responsiveness to various cytokines is critical
to maintaining normal thymopoiesis. For example,
genetic defects in the common cytokine receptor g
chain results in X-linked severe combined immunodefi-
ciency (SCID) [16]. IL-7 is known to be particularly
important in modulating thymocyte survival through
various checkpoints [17]. Furthermore, IL-7 deficient
mice have reduced numbers of thymocytes as well as
skewed ratios of ab versus g δ T cells [18]. While less is
known about the contribution of other cytokines to thy-
mocyte development, engineered loss of the IL-6 recep-
tor a chain (IL-6Ra) has a noticeable impact on
thymopoiesis [19].
Here we describe the use of a panel of commercially
available mAbs that can be employed to simultaneously
identify and phenotype 21 thymocyte subsets that span
across T cell development. These subsets include 18
subsets previously defined by others, and three subsets
recently described by us[13]. We demonstrate the utility
of this staining scheme by quantifying the expression of
Figure 1 Mouse thymocyte development scheme. Mouse T cells develop in the thymus from early thymic progenitors (ETPs) to mature
thymocytes that are single positive for CD4 (SP4) or CD8 (SP8). (A) shows the maturational pathway from the ETPs to the intermediate CD8
single positives (ISPs). (B) shows the maturation from the ISP stage to the most mature single positive stages. DP = double positive for CD4 and
CD8, DN = double negative for CD4 and CD8, TCR = T cell receptor. Surface antigens used to discriminate the subsets and important
developmental events are noted. Thymocyte subsets not directly in the T cell lineage are not depicted. Non-T-lineage markers (Lin) used for
discrimination are also not depicted.
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(CD126) in the thymocyte subpopulations.
Results
Ten color flow cytometry discriminates thymocyte
subpopulations
Figure 2 shows the 10-color staining and gating scheme
we have developed to comprehensively discriminate thy-
mocyte subpopulations across development using a sin-
gle stain. This scheme leaves the PE channel open for
assessment of the relative expression of an additional
antigen in each of the subpopulations. The ratios of the
major populations of DN, DP, SP4, and SP8 cells and
relative staining patterns were similar to those pre-
viously published [20-22]. These populations were
further parsed into the indicated subsets, which again
showed expected staining patterns previously published
with less comprehensive staining methods. Importantly,
this staining scheme allowed for the discrimination of
subsets from the earliest DN1 populations throughout
development to the most mature SP populations, with-
out the need for cell sorting or multiple stains (Figure
1). Table 1 shows the average percentages of each of the
21 subpopulations from 10 individual mice. Of note, the
use of CD25 expression relative to CD28 expression not
only discriminated between pre-b-selected and post-b-
selected cells [10], but also showed a DN CD44 nega-
tive, CD28 positive, CD25 intermediate population that
we recently defined as DN3c [13]. This staining scheme
also illuminates DN4 subsets which we define as DN4a
(CD25
-CD28
int), DN4b (CD25
-CD28
hi), and DN4c
(CD25
-CD28
-) [13]. The DN4b cells express high levels
Figure 2 Gating strategy used for the 10-color flow cytometric stain. Thymocytes were phenotyped by flow cytometry with Annexin-V-FITC
and mAbs against mouse CD4, CD8, CD25, CD28, CD44, CD117, CD24, TCR-b and either IL-4Ra (CD124) or IL-6Ra (CD126). Only singlets and
Annexin-V negative cells were included in the analysis. Cells of other lineages were excluded using mAbs against the markers NK1.1, Ly6, Ter119,
CD19, CD11b, and TCR-gδ. Arrows show the logical gating progression used to achieve discrimination of the 21 subsets. Forty million thymocytes
were stained to generate this figure.
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thymocytes that fail to express CD4 and CD8 (data not
shown). Our previous OP9-DL1 fate mapping assays
showed that DN3c cells give rise to DN4a cells which
represent preDP cells in the DN compartment[13]. The
advantage of this polychromatic scheme is the ability to
enumerate and characterize all these populations simul-
taneously without the need for pre-sorting or separate
stains. We also validated the ten-color stain by compar-
ing it with a simpler six-color stain that used different
combinations of antibodies. As shown in Additional File
1 Figure S1, the distributions of the major thymocyte
subsets were very similar between the two staining
schemes.
Assessment of CD124 and CD126 expression during T cell
development
To show the utility of the 10-color staining scheme, we
assessed surface expression of two potentially important
cytokine receptors across thymocyte development (Fig-
ure 3). The ratios of the median fluorescent intensities
for CD124 (IL-4Ra) and CD126 (IL-6Ra) relative to the
corresponding isotype controls, and adjusted for FSC
differences, are shown in Figure 3A (and summarized in
Additional File 2 Table S1). These stains revealed two
distinct patterns of expression. CD124 expression was
very high on DN1a and DN1b early T cell precursors
(ETPs), whereas CD126 showed very low expression on
the ETPs. As the cells progressed from ETPs to the
DN2 populations, they retained expression of CD124
but expression of this receptor waned as the thymocytes
approached the b-selection checkpoint (DN3a stage). As
we have previously published, TCR
- and TCR
lo DP cells
showed little expression of CD126 but high expression
of CD124 [23]. The most mature populations of SP4
and SP8 cells expressed both cytokine receptors. Of par-
ticular note, CD126 was highly expressed only on the
most mature SP4 and SP8 populations (CD24
lo cells)
and two very small DN1 subsets (DN1d, DN1e) that are
reportedly not efficient precursors to mature T cells [8].
IL-6 signaling via pSTAT1 correlates with expression of IL-
6Ra in the CD24
loSP4 and CD24
loSP8 populations
An IL-6 response assay was performed to determine
whether the limited IL-6Ra (CD126) expression pattern
shown in Figure 3A correlated with a similar pattern of
responsiveness to IL-6 (Figure 3B). The CD24
hiSP4,
CD24
loSP4, CD24
hiSP8, and CD24
loSP8 subsets were
sort purified as described in the Materials and Methods.
Cells were assessed for response to IL-6 as previously
described [17,23]. Cells were treated for 20 minutes in
t h ep r e s e n c eo ra b s e n c eo f2 5n g / m lo fI L - 6a n d
Table 1 Relative distribution of the 21 thymocyte subsets*
Average percentage (%) STDEV (%) Range (%) Lower/upper 95% CI of mean (%)
DN1a 0.00107 0.000274 0.000881-0.00151 0.00073-0.00141
DN1b 0.0117 0.00214 0.00865-0.0146 0.00903-0.0143
DN1c 0.00115 0.000308 0.000713-0.00149 0.000772-0.00154
DN1d 0.00528 0.00089 0.00429-0.00650 0.00417-0.00638
DN1e 0.00510 0.00104 0.00391-0.00660 0.00381-0.00639
DN2a 0.0175 0.00357 0.0123-0.0205 0.0130-0.0219
DN2b 0.0769 0.00401 0.0725-0.0834 0.0720-0.0819
DN3a 1.205 0.145 1.053-1.420 1.0249-1.386
DN3b 0.179 0.0154 0.153-0.193 0.160-0.198
DN3c 0.170 0.0204 0.135-0.184 0.144-0.195
DN4a 1.528 0.296 1.197-1.789 1.160-1.894
DN4b 0.385 0.0879 0.290-0.494 0.276-0.495
DN4c 0.169 0.107 0.0675-0.290 0.0360-0.302
ISP 0.672 0.0892 0.552-0.731 0.561-0.783
TCR
lo DP 73.933 1.938 71.609-76.656 71.527-76.340
TCR
int DP 14.146 1.435 13.082-16.261 12.364-15.928
TCR
hi DP 1.113 0.141 0.944-1.265 0.938-1.288
CD24
hi SP4 3.862 0.216 3.504-4.0475 3.593-4.131
CD24
lo SP4 1.0966 0.0944 0.973-1.204 0.979-1.214
CD24
hi SP8 0.872 0.110 0.696-0.949 0.736-1.009
CD24
lo SP8 0.604 0.0235 0.582-0.638 0.575-0.633
* Mean percentages and SDs are derived from stains performed on thymuses from 10 individual C57BL/6 mice using ten million thymocytes from each mouse.
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Page 4 of 9responsiveness assessed by intracellular staining, using
mAbs specific to the phosphorylated form of STAT1
(pSTAT1). As predicted from the pattern of surface
expression of the IL-6Ra, IL-6 responsiveness was most
evident in the mature CD24
loSP4 and CD24
loSP8
populations.
Discussion
The 10-color stain described above allowed us to easily
define the relative distribution of 21 discreet thymocyte
subsets (Table 1) and to quantitate cytokine receptor
surface expression across development at much finer
resolution than previously reported. We have previously
demonstrated that CD4-CD8-thymocytes are a mixed
population with regard to IL-4-induced intracellular sig-
naling as assessed by pSTAT5 [23]. In this study we
further divided the DN compartment into 13 separate
populations and a clearer picture emerged of IL-4Ra
expression during early thymocyte development. The
DN3a, DN3b, and the DN3c populations exhibited very
little surface expression of IL-4Ra (Figure 3A), suggest-
ing loss of IL-4 signaling occurs in T cell development
before cells undergo b-selection. IL-4 receptor was upre-
gulated in the more mature thymocyte populations (DP
and SP cells). There is an apparent disconnect between
the expression levels of the IL-4 receptor shown in
Figure 3A and previous findings detailing the extent of
thymocyte signaling via IL-4 [23,24]. We have previously
shown that DP thymocytes have diminished levels of
IL-4 responsiveness compared to SP cells [23], which
m a yb ed u et os u p p r e s s i o nv i aS O C S - 1a sr e p o r t e db y
Yu et al. [24].
Within the standard ab T cell development pathway,
we show that IL-6Ra expression is restricted to only the
most mature SP4 and SP8 populations (Figure 3A).
These populations are defined as semi-mature and
mature based on high or low expression of CD24 as
previously described [7,15]. We also demonstrated that
Figure 3 Surface expression of CD124 and CD126, and IL-6 signaling. The 10-color flow cytometric staining scheme shown in Figure 2 was
used to evaluate expression of the cytokine receptors CD124 and CD126 (A). The FSC-adjusted MFI values for each receptor-specific stain were
divided by the MFI values obtained from each corresponding isotype control stain to generate the ratios shown in the graph. A ratio of 1
indicates no change compared to isotype control. Bars represent the average MFI values from ten separate experiments and the error bars
represent SD. Ten million cells were stained for each experiment shown in (A). In (B), surface staining of CD4, CD8 and CD24 was used to sort
CD24
loSP4, CD24
hiSP4, CD24
loSP8, and CD24
hiSP8 populations. Sorted cells were subsequently treated with (open histograms) and without
(shaded histograms) 25 ng/ml IL-6 as described in the methods section. Inducible IL-6 signaling was assessed by intracellular pSTAT-1-PE
staining. The assay in (B) is representative of three experiments. 250,000 sort-purified cells from each indicated subset were used for the
experiment shown.
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and DN1e) also expresses this receptor, however, the
subsets of DN1 that are reported to be efficient T cell
progenitors (DN1a and DN1b) were very low or nega-
tive for IL-6Ra. Intracellular staining for IL-6-induced
phosphorylation of STAT-1( F i g u r e3 B )a n dS T A T - 3
(data not shown) clearly indicated that only the most
mature SP subsets were capable of responding to IL-6
stimulation. These data confirm and expand on the pre-
v i o u sf i n d i n g sb yB e t za n dM u l l e rw h of i r s tp r o p o s e d
IL-6Ra as a marker for mature thymocytes in mice [25].
They demonstrated that gp130 (IL-6 receptor signaling
subunit) is expressed at consistent levels throughout
thymocyte maturation while IL-6Ra is found only in the
SP populations. They also showed that IL-6Ra
+ SP4 thy-
mocytes represented a more mature population as they
were not sensitive to hydrocortisone and were able to
proliferate in response to TCR crosslinking, unlike the
IL-6Ra
- SP4 population. Use of our novel staining
method, which examined IL-6Ra at a higher resolution
across development, confirmed IL-6Ra as a marker for
mature SP thymocytes. Importantly, our experiments
using sort purified cells showed that IL-6-induced STAT
signalling is confined to the mature SP subsets as would
be predicted by IL-6Ra staining.
The exact role of IL-6 in thymopoiesis is unknown;
however, it may augment responsiveness of the mature
populations to other cytokines. For example, Suda, et al.
[26] demonstrated that IL-6 increased the proliferative
response of SP4 and SP8 thymocytes to IL-2 and IL-4 in
vitro. Additionally there is a significant loss of total thy-
mocyte numbers in IL-6 deficient mice [19]. Sempowski
et al. reported that in human thymus samples, IL-6 tran-
script increases progressively during aging [27]. Interest-
ingly, they also reported that in vivo injection of mice
with IL-6 over the course of 3 days led to thymic atro-
phy and particular loss of DP thymocytes, a population
we find to express little, if any IL-6Ra. Given these
observations it is clear that our understanding of the
role of IL-6 within the thymus is incomplete and further
study is warranted.
Conclusions
The staining scheme that we present in this manuscript
allowed us to simultaneously characterize 21 cell subsets
that spanned T cell development in the thymus. We
found distinct expression patterns of the receptors for
IL-4 and IL-6 as thymocytes develop. Importantly, cell
sorting was not necessary to pre-enrich the populations
prior to analysis of surface receptor expression, which
allowed for rapid phenotyping of thymopoiesis utilizing
fewer mice. This method was designed to use only com-
mercially available mAb-fluorochrome conjugates in
order to allow any investigator with access to a four-
laser flow cytometer the ability to employ the staining
scheme to quickly and efficiently characterize mouse
thymopoiesis in normal or genetically manipulated mice.
Methods
Flow Cytometer Setup and Data Acquisition
Flow cytometric data were acquired using a BD LSR II
Flow Cytometer (BD Biosciences, San Jose, CA). This
instrument is an air-cooled 4-laser benchtop flow cyt-
ometer with the ability to detect up to 12 individual
fluorescent signals. The lasers and filters used were sup-
plied with the instrument from BD Biosciences. The
lasers used in this study were the following: solid state,
50 mW, 488 nm (blue); solid state, 50 mW, 405 nm
(violet); solid state, 150 mW, 532 nm (green); helium-
n e o n ,7 0m W ,6 3 3n m( r e d ) .T h ep h o t o m u l t i p l i e r
(PMT) setup is depicted in Additional File 3 Figure S2
and used a trigon configuration for blue, violet, and red
laser paths and an octagon configuration for the green
detector arrays. Dichroic long pass mirrors were used
on the inner rings, and band pass filters used on outer
rings. A 2-Blue, 2-Violet, 5-Green, 3-Red fluorochrome
excitation configuration was used in this study (Addi-
tional File 3 Figure S2). Instrument performance was
validated using BD Cytometer Setup and Tracking
(CS&T) beads (part #: 910723, Lot ID: 75445, BD Bios-
ciences, San Jose, CA). This validation was performed
routinely and prior to each of the large phenotyping
experiments. Triggering was set on the forward scatter
(FSC) signal. FACS DIVA 6.0 software (BD Biosciences)
was used to acquire digital data.
Fluorochrome Compensations and PMT Settings
Although PMT settings and compensations should be
adjusted for each instrument and stain setup, we include
here the settings used for our instrument which were
the following: the FSC setting included both area and
width, with a threshold of 10,000, and a PMT Voltage
of 315. The SSC setting included area with a PMT vol-
tage of 300. All other PMT settings (log scale) were as
follows: Pacific Blue = 380, APC = 545, APC-Cy7 = 568,
FITC = 539, PerCP = 642, PE = 577, PE-Texas Red =
501, PE-Cy5.5 = 479, PE-Cy7 = 551, and Pacific Orange
= 468. The PMT voltage settings were manually set
using unstained cells as a reference. Each histogram was
adjusted to allow a full view of the peak at approxi-
mately the same intensity for each fluorochrome.
Unstained and single fluorochrome-mAb stained thy-
mocytes were used to establish baseline instrument
application settings and compensation settings for each
fluorochrome measured. To determine and validate
compensation settings for fluorescence on small popula-
tions, cells of interest were sort enriched prior to use.
Preliminary experiments were designed to first assess
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the staining patterns observed in these smaller panels
were compared with those previously observed in simple
two-, three-, or four-color experiments. After compar-
able results were obtained, an additional interest marker
was added, and separate “fluorescence minus one”
( F M O )c o n t r o l sw e r ep r e p a r e dt oe n s u r et h a tt h es t a i n -
ing patterns and all subset populations of the original
markers were not changed by the addition of the new
marker. FMO control histograms are shown in Addi-
tional File 4 Figure S3. Using this sequence, the 10-color
staining panel was eventually successfully validated.
Cell Sorting
For the pSTAT assays shown in Figure 3B, the cell sub-
sets indicated in the figure legend were sort-purified
using a two-laser Moflo cell sorter (Beckman-Coulter,
Fullerton, CA) and Summit v4.3 software. For the vali-
dation of compensation settings for the small DN thy-
mocyte subsets, cells were stained with a single
fluorochrome and sort-enriched using the MoFlo cell
sorter prior to use on the LSR II. These cells were
stained and positively enriched using one of the follow-
ing mAb or mAb combinations: cKit-APC, CD25-
PerCP, CD44-APC-Cy7, or Lin-biotin/TCR gδ-biotin fol-
lowed by streptavidin-PE-Texas Red.
Data Analysis
Data were analyzed using FACS DIVA 6.0 software (BD
Biosciences). For all experiments, cell doublets and clus-
ters were gated from the analysis using doublet discrimi-
nation (FSC width versus FSC area). Cell debris and
small particles were excluded by gating out events with
low forward scatter. The gating strategy is shown in Fig-
ure 2. CD4 and CD8 double positive and single positive
populations that were negative for the non-T lineage
markers (Lin) and TCR-gδ were further discriminated as
follows: DP (CD4
+CD8
+), SP4 (TCR
+CD4
+CD8
-), and
SP8 (TCR
+CD4
-CD8
+). DP TCR negative, DP TCR
intermediate, and DP TCR high were separated by TCR-
b chain (H57-597) expression. CD4
-CD8
- (DN) popula-
tions were further defined as follows: DN1 (Lin
-CD25
-
CD44
+), DN2 (Lin
-CD25
+CD44
+), DN3 (Lin
-CD25
+CD44
-) and DN4 (Lin
-CD25
-CD44
-). Five subsets of
TCR negative DN1 thymocytes (DN1a-DN1e), as
defined by c-Kit and CD24 expression were discrimi-
nated as previously demonstrated [8]. DN3 and DN4
were also further defined based on CD25 and CD28
expression. DN3 cells were divided into CD28 low/
CD25 high (DN3a), CD28 intermediate/CD25 high
(DN3b) and CD28 intermediate/CD25 intermediate
(DN3c). DN4 cells were divided into CD28 intermediate
(DN4a), CD28 high (DN4b), and CD28 low (DN4c) cells
as described in the results section.
In Figure 3, median fluorescent intensity (MFI) ratios
were calculated based on the FSC-adjusted MFI values
of the indicated specific cytokine receptor stains divided
by the FSC-adjusted MFI values from the corresponding
isotype control stains. FSC adjustment (PE MFI/FSC
MFI) was done in order to account for cell size differ-
ences in the different subsets. This also allowed for nor-
malization across the multiple experiments. MFI ratio
averages and standard deviations were calculated from a
minimum of five separate experiments for each cytokine
receptor. To do overlay plots, FCS data were exported,
a n da n a l y z e db yF l o w J o( T r e eS t a r ,I n c ,A s h l a n d ,O R ) .
Statistical analysis was generated using GraphPad Prism
v. 4.00 (La Jolla, CA).
Mice
Mice used in this study were C57BL/6 females ranging
from 6 to 8 weeks of age that were bred and housed at
U.S.D.A. approved animal facilities located at the Uni-
v e r s i t yo fO k l a h o m ai nT u l s aa n dt h eU n i v e r s i t yo f
Tulsa. Animal care and all animal experiments were
done in accordance with procedures outlined in the
Guide for the Care and Use of Laboratory Animals
(National Research Council). Protocols were reviewed
and approved by the Institutional Animal Care and Use
Committees of the University of Oklahoma Health
Sciences Center and the University of Tulsa.
Tissue harvest and cell staining
Thymuses were harvested and placed into complete
tumor media (CTM) as previously described [28]. Thy-
muses were pressed through 70-μm nylon screens to
generate single thymocyte suspensions [17]. Cells were
treated with RBC lysis buffer (Sigma-Aldrich, St. Louis,
MO), washed into CTM and counted using a hemocyt-
ometer. Cells were incubated with mAb against mouse
CD16/CD32 (Fc Block, BD Biosciences) to block poten-
tial Fc-mediated binding and then stained at a density of
1×1 0
8 cell/ml with primary mAbs as indicated in Addi-
tional File 5 Table S2 for 45 minutes at 4°C in the dark.
After two washes, the cells were further stained with
Streptavidin PE-Texas Red (1:1600) for 30 minutes at 4°
C in the dark. The monoclonal antibodies used in the
10-color stain experiments were individually tested.
Optimal antibody titers (Additional File 5 Table S2)
were determined for each monoclonal antibody and/or
their secondary stain (Streptavidin PE-Texas Red) by
staining thymocytes with mAb titers ranging from 1:50
to 1:1600, depending on the fluorochrome. For
Annexin-V (Biolegend) staining, cells were washed twice
after surface marker staining, then resuspended in
Annexin-V binding buffer (Biolegend containing
Annexin-V-FITC (1:100), and incubated for 15 minutes
at room temperature in the dark.
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Assessment of IL-6-induced STAT-1 phosphorylation
began with surface staining of total thymocytes with
anti-CD4, CD8, and CD24 mAbs (Additional File 5
Table S2). These cells were sort-purified into the follow-
ing populations: CD24
loSP4, CD24
hiSP4, CD24
loSP8, and
CD24
hiSP8. Sorted cells were then incubated in the pre-
sence or absence of 25 ng/ml IL-6 (R&D Systems, Min-
neapolis, MN) for 20 minutes at 37°C. Intracellular
stains were performed using Invitrogen/Caltag Fix &
Perm reagents with an additional methanol step as pre-
viously described[23]. STAT-1 phosphorylation status
was assessed with PE-conjugated anti-pSTAT1 (pY701)
(BD Biosciences) using a PE-conjugated mouse IgG2a
(BD Biosciences) as an isotype control.
Additional material
Additional file 1: Figure S1-Frequencies of the major thymocyte
populations in the ten-color stain compared to a simpler six-color
stain. The six-color stain used was CD4-APC, CD8-pacific blue, CD25-PE,
CD44-APC-Cy7, TCR-b-FITC, and T-lineage-biotin followed by SA-PE-TR.
Frequencies of major thymocyte subsets are annotated in the figure. This
figure represents one of five separate experiments that showed similar
results.
Additional file 2: Table S1. CD124 and CD126 expression across 21
thymocyte subsets from 10-color stain.
Additional file 3: Figure S2-The BD LSRII flow cytometer PMT/laser
configuration. The flow cytometer used in this study included: 2 PMTs/
Blue laser; 2 PMTs/Violet laser; 5 PMTs/Green laser; 3 PMTs/Red laser
configuration from the manufacturer. Light paths for each laser are
depicted by arrows.
Additional file 4: Figure S3-Fluorescence minus one (FMO) controls.
The FMO histograms for each of the nine stains used to discriminate the
thymocyte subsets.
Additional file 5: Table S2. Staining reagents used in the 10-color stain.
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